Designer Brands (NYSE: DBI), the company behind the DSW shoe warehouse chain, reported second-quarter results on Sept. 10 that handed its long-suffering owners something they had not seen in years: a clean profit surprise and a raised full-year forecast. Adjusted earnings of $0.34 a share beat the consensus estimate by roughly 30%, gross margin jumped, total debt fell $93 million from a year earlier, and management lifted 2026 adjusted EPS guidance to $0.47–$0.52 from $0.28–$0.38. The beaten-down stock jumped about 14% over five sessions and now trades near $5.90, still far below its 52-week high of $9.17.
The same report, though, showed why this was never a simple turnaround. That headline gross-margin jump—up 430 basis points—included 280 basis points from one-time tariff refund claims; the underlying operational gain was a real but smaller 150 basis points. And the business at the center of the story still shrank: DSW comparable-store sales fell 2.6% in the quarter.
Why the bear case got so loud
To appreciate what changed, you need the recent history. In fiscal 2025 (the year ended Jan. 31, 2026), net sales fell 3.9% to about $2.9 billion, comparable sales dropped 4.3% for the year, and adjusted EPS shrank to $0.16 from $0.27. The stock at one point touched a 52-week low near $3.11. The selloff had two engines: a DSW retail engine that kept losing sales, and a balance sheet that had taken on debt to build a portfolio of owned brands—Topo Athletic, Jessica Simpson, Keds—just as the retail core was weakening. Add a heavily promotional footwear market, and there was a coherent reason the stock carried a sell view and the confidence thin.
Quick Backtesting Tool
What actually reversed
The second-quarter evidence said the downward spiral has at least stalled. Fully funded debt fell to $423.1 million, down over $93 million year over year, and combined cash and undrawn credit lines gave the company roughly $198 million in liquidity—the sort of cushion that changes the phrase from "balance-sheet risk" to "a fixable story." Comparable-sales declines have narrowed for a stretch of quarters, from 7.8% in early 2025 to the mid-single digits and now 2.4% overall in the latest quarter. Management has now raised guidance twice.
The growth engine is the small Brand Portfolio segment, up 17.9% in the quarter to $86.3 million, where direct-to-consumer comparable sales swung from a 29.2% decline a year ago to plus 7.1%. Topo Athletic grew more than 24% and is being steered toward over $100 million in revenue in 2027, and the segment turned an operating profit after losing $4 million a year earlier. Management says back-to-school is running ahead of expectations.
The valuation bridge
At a roughly $300 million market cap, the stock trades in the low teens on the raised 2026 adjusted EPS guidance, near book value, and at about 4.5 times EV/EBITDA with a 3.3% dividend yield. That put it in line with footwear peers Caleres and Genesco—both around or below 4.5 times EBITDA—which is what a flat-to-declining retail core is worth. The market is not paying a premium for the turnaround; it is pricing the DSW risk and waiting for proof. The declared quarterly dividend is $0.05 per share, roughly $11 million a year—small next to the roughly $120 million of trailing free cash flow reported, though that cash figure is flattered by tariff refunds and working-capital timing, so the yield is support, not the thesis.
The honest call
Has the strong sell run its course? Yes. The two things that made the stock dangerous—a collapsing margin and a leveraged balance sheet—have demonstrably reversed while the multiple compressed, which is exactly the risk/reward reset that turns a fallen stock from danger into a candidate. Dropping a sell never required DSW to be growing again.
Turning that reset into a fresh buy is a higher bar that the next two to four quarters have to meet: retail comps must stop declining on a sustained basis, and the margin gain must hold once the tariff refunds roll off. That is the piece still missing, and it is why this is a "the sell is over" story rather than a proven turnaround. The stock already trades as if the worst is behind it; what it has not yet earned is the multiple a recovered one would carry.
